Brinzolamide 1% Ophthalmic Suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Brinzolamide 1% Ophthalmic Suspension, covering 2020-03-02 to 2020-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes [Phase 3]